Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Abreu

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Physical Review Letters|September 28, 2010
Tolman mass, generalized surface gravity, and entropy boundsGabriel Abreu, Matt Visser
Microbiology Resource Announcements|February 6, 2025
Genome sequences of <i>Klebsiella pneumoniae</i> bacteriophages SF_KL2 and SF_KL25Sophia Lorenz, Gabriel Abreu, Hugo Oliveira
Microbiology Resource Announcements|March 25, 2024
Genome sequence of <i>Erwinia amylovora</i> bacteriophage OmenGabriel Abreu, Edgar Garcia, Ana Oliveira, et al.
Journal of Medical Primatology|March 17, 2020
Haematological and biochemical parameters of wild capuchin monkeys in Brasília, Federal District-BrazilGabriel Abreu Sousa, Giane Regina Paludo, Danilo Simonini Teixeira, et al.
Annals of the Rheumatic Diseases|January 23, 2023
Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosusEric F Morand, Gabriel Abreu, Richard A Furie, et al.
Journal of Biomechanics|February 10, 2016
In vivo passive mechanical properties estimation of Achilles tendon using ultrasoundLiliam Fernandes de Oliveira, Carolina Carneiro Peixinho, Gabriel Abreu Silva, et al.
Rheumatology (Oxford, England)|March 11, 2022
Causal cascade of direct and indirect effects of anifrolumab on patient-reported outcomes: structural equation modelling of two Phase 3 trialsDonald Stull, Sean O'Quinn, Betsy Williams, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 23, 2020
Long-Term Safety and Efficacy of Anifrolumab in Adults With Systemic Lupus Erythematosus: Results of a Phase II Open-Label Extension StudyW Winn Chatham, Richard Furie, Amit Saxena, et al.
Lupus Science & Medicine|February 18, 2021
Safety profile of anifrolumab in patients with active SLE: an integrated analysis of phase II and III trialsRaj Tummala, Gabriel Abreu, Lilia Pineda, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 29, 2021
What Does It Mean to Be a British Isles Lupus Assessment Group-Based Composite Lupus Assessment Responder? Post Hoc Analysis of Two Phase III TrialsRichard Furie, Eric F Morand, Ian N Bruce, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Physical Review Letters|September 28, 2010
Tolman mass, generalized surface gravity, and entropy boundsGabriel Abreu, Matt Visser
Microbiology Resource Announcements|February 6, 2025
Genome sequences of <i>Klebsiella pneumoniae</i> bacteriophages SF_KL2 and SF_KL25Sophia Lorenz, Gabriel Abreu, Hugo Oliveira
Microbiology Resource Announcements|March 25, 2024
Genome sequence of <i>Erwinia amylovora</i> bacteriophage OmenGabriel Abreu, Edgar Garcia, Ana Oliveira, et al.
Journal of Medical Primatology|March 17, 2020
Haematological and biochemical parameters of wild capuchin monkeys in Brasília, Federal District-BrazilGabriel Abreu Sousa, Giane Regina Paludo, Danilo Simonini Teixeira, et al.
Annals of the Rheumatic Diseases|January 23, 2023
Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosusEric F Morand, Gabriel Abreu, Richard A Furie, et al.
Journal of Biomechanics|February 10, 2016
In vivo passive mechanical properties estimation of Achilles tendon using ultrasoundLiliam Fernandes de Oliveira, Carolina Carneiro Peixinho, Gabriel Abreu Silva, et al.
Rheumatology (Oxford, England)|March 11, 2022
Causal cascade of direct and indirect effects of anifrolumab on patient-reported outcomes: structural equation modelling of two Phase 3 trialsDonald Stull, Sean O'Quinn, Betsy Williams, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 23, 2020
Long-Term Safety and Efficacy of Anifrolumab in Adults With Systemic Lupus Erythematosus: Results of a Phase II Open-Label Extension StudyW Winn Chatham, Richard Furie, Amit Saxena, et al.
Lupus Science & Medicine|February 18, 2021
Safety profile of anifrolumab in patients with active SLE: an integrated analysis of phase II and III trialsRaj Tummala, Gabriel Abreu, Lilia Pineda, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 29, 2021
What Does It Mean to Be a British Isles Lupus Assessment Group-Based Composite Lupus Assessment Responder? Post Hoc Analysis of Two Phase III TrialsRichard Furie, Eric F Morand, Ian N Bruce, et al.
Pageof 3